Bausch Health (BHC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
8 Apr, 2026Voting matters and shareholder proposals
Shareholders will vote on the election of ten directors, each recommended by the board for approval.
An advisory vote will be held on the compensation of Named Executive Officers.
Appointment of PricewaterhouseCoopers LLP as external auditor until the 2027 Annual Meeting, with authorization for the board to set remuneration.
Additional business may be addressed if properly brought before the meeting.
Board of directors and corporate governance
The slate of director nominees includes Thomas J. Appio, Christian A. Garcia, Michael Goettler, Sarah B. Kavanagh, Frank D. Lee, Sandra Leung, John A. Paulson, Robert N. Power, Eiry W. Roberts, M.D., and Amy B. Wechsler, M.D.
Executive compensation and say-on-pay
Shareholders will cast an advisory vote on the compensation of Named Executive Officers.
Latest events from Bausch Health
- Board recommends approval of all proposals, with strong focus on pay-for-performance and ESG.BHC
Proxy filing8 Apr 2026 - 11th straight quarter of revenue and EBITDA growth, with strong segment results and lower net debt.BHC
Q4 202520 Feb 2026 - Q2 2024 revenue up 11% to $2.40B, adjusted EBITDA up 10%, and debt reduced by $360M.BHC
Q2 20242 Feb 2026 - Q3 revenue up 12%, Adjusted EBITDA up 10%, guidance raised, and all segments grew.BHC
Q3 202417 Jan 2026 - Strong 2024 results and 2025 growth outlook driven by GI, aesthetics, and neuroscience franchises.BHC
44th Annual J.P. Morgan Healthcare Conference15 Jan 2026 - Full-year revenue and adjusted EBITDA rose 10%, with all segments contributing to growth.BHC
Q4 202429 Dec 2025 - Q1 2025 revenue up 5% to $2.26B; $7.9B refinancing extends debt maturities and boosts flexibility.BHC
Q1 202522 Dec 2025 - Growth in GI, Solta, and international markets, with XIFAXAN exclusivity and trial data as key focus.BHC
Evercore ISI 8th Annual HealthCONx Conference3 Dec 2025 - Board recommends approval of all annual meeting proposals, with strong governance and ESG focus.BHC
Proxy Filing2 Dec 2025